结合免疫疗法与跨动脉放射栓塞治疗
Zeynep Ceren Balaban Genc1, Efe Soydemır2, Seval Ay Ersoy3
1Department of Nuclear Medicine, Pendik Training and Research Hospital, Marmara University, Istanbul, Turkey.
概括
本案例报告表明,将跨动脉放射栓塞与免疫疗法 (阿特佐利祖马布和贝瓦齐祖马布) 结合起来,是晚期肝细胞癌 (HCC) 的有效治疗策略. 这种组合为管理这种具有挑战性的癌症提供了有希望的方法.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 在瘤学瘤学.
- 放射学 放射学是指放射学
背景情况:
- 肝细胞癌 (HCC) 是一个重大的全球健康挑战,死亡率高.
- 晚期诊断和传统疗法的有效性有限,需要针对不可切除的HCC制定新的治疗策略.
研究的目的:
- 报告一个案例,证明跨动脉放射栓塞和免疫治疗在HCC管理中的联合疗效.
- 突出一个潜在的新治疗模式,先进的HCC.
主要方法:
- 该研究涉及一个案例报告,详细介绍了跨动脉放射栓塞的应用.
- 免疫疗法药物,特别是阿特佐利祖马布和贝瓦齐祖马布,被同时使用.
主要成果:
- 跨动脉放射栓塞和免疫治疗 (阿特佐利祖马布和贝瓦齐祖马布) 的联合方法在治疗高血压瘤中被证明是有效的.
- 这种多式联络策略为无法切除疾病的患者提供了可行的替代方案.
结论:
- 跨动脉放射栓塞与免疫治疗结合,代表了肝细胞癌的有希望和有效的治疗选择.
- 这种组合疗法需要进一步研究,以便在HCC治疗中得到更广泛的应用.
相关概念视频
01:27Tumor Immunotherapy
567
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
567
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K